UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000024374
Receipt number R000028043
Scientific Title Changes in trace substances in peripheral blood following electroconvulsive therapy in patients with depression: a longitudinal observational study
Date of disclosure of the study information 2016/10/17
Last modified on 2023/04/18 16:34:48

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Changes in trace substances in peripheral blood following electroconvulsive therapy in patients with depression: a longitudinal observational study

Acronym

Changes in trace substances in blood following electroconvulsive therapy

Scientific Title

Changes in trace substances in peripheral blood following electroconvulsive therapy in patients with depression: a longitudinal observational study

Scientific Title:Acronym

Changes in trace substances in blood following electroconvulsive therapy

Region

Japan


Condition

Condition

1. Inpatients with major depressive disorder
2. Healthy controls.

Classification by specialty

Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine changes in trace substances in peripheral blood following electroconvulsive therapy, using metabolomics with mass spectrometry, in patients with depression.

Basic objectives2

Others

Basic objectives -Others

To screen biological markers for depression.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Changes in trace substances in peripheral blood following electroconvulsive therapy.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

[Patients with depression]
1) Inpatients at Department of Neuropsychiatry, Keio University Hospital.
2) Major depressive disorder according to DSM5.
3) Twenty years or older of age and being capable of providing consent or presence of substitute decision maker.
4) Being supposed to receive ECT and/or antidepressant treatment.

[Healthy controls]
1) Volunteers who was matched age and gender to the patients with major depressive disorder who receive electroconvulsive therapy.
2) No presence of any psychiatry diagnosis.
3) No presence of psychiatry history.
4) Twenty years or older of age and being capable of providing consent.

Key exclusion criteria

[Patients with depression]
1) Presence of unstable physical illness.
2) History of electroconvulsive therapy for the past 6 months.
3) History of alcohol or any substance abuse for the past 6 months.
4) History of head trauma accompanied with severe neurological aftereffects.
5) History of vagal reflex induced by blood draw.

[Healthy controls]
1) Presence of unstable physical illness.
2) History of vagal reflex induced by blood draw.
3) Those who are involved in this research.
4) Those who are exposed to potential pressure from investigators.

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Hiroyuki
Middle name
Last name Uchida

Organization

Keio University School of Medicine

Division name

Department of Neuropsychiatry

Zip code

160-8582

Address

35 Shinanomachi, Shinjuku-ku, Tokyo,160-8582, Japan.

TEL

03-5363-3829

Email

hiroyuki.uchida.hu@gmail.com


Public contact

Name of contact person

1st name Hiroyuki
Middle name
Last name Uchida

Organization

Keio University School of Medicine

Division name

Department of Neuropsychiatry

Zip code

160-8582

Address

35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.

TEL

03-5363-3829

Homepage URL


Email

hiroyuki.uchida.hu@gmail.com


Sponsor or person

Institute

Department of Neuropsychiatry, Keio University, School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Department of Neuropsychiatry, Keio University, School of Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Keio University School of Medicine Ethics Committee.

Address

35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.

Tel

03-5363-3503

Email

med-rinri-jimu@adst.keio.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 10 Month 17 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 10 Month 03 Day

Date of IRB

2016 Year 10 Month 03 Day

Anticipated trial start date

2016 Year 10 Month 18 Day

Last follow-up date

2024 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

To examine changes in trace substances in peripheral blood following electroconvulsive therapy, using metabolomics with mass spectrometry, in patients with depression.


Management information

Registered date

2016 Year 10 Month 12 Day

Last modified on

2023 Year 04 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028043


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name